close

Clinical Trials

1 208 209 210
Number of results: 4190

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
0000-00-00 IMCgp100 uveal melanoma 1 Immunocore (UK) Cancer - Oncology
0000-00-00 delafloxacin acute bacterial skin and skin structure infections (ABSSSI) 3 Melinta Therapeutics (USA - CT) Infectious diseases
0000-00-00 acute bacterial skin and skin structure infections (ABSSSI) Infectious diseases
0000-00-00 ESKAPE Pathogen Program including RX-P873 preclinical Melinta Therapeutics (USA - CT) Infectious diseases
0000-00-00 bb2121 anti-BCMA CAR T cells multiple myeloma 1 Bluebird bio (USA - MA) Cancer - Oncology
0000-00-00 GS010- adeno-associated viral vector containing the human NADH dehydrogenase 4 gene Leber hereditary optic neuropathy (LHON) 1-2 Gensight Biologics (France) Ophtalmological diseases - Genetic diseases - Rare diseases
0000-00-00 brilacidin-OM 2 Cellceutix (USA - MA), now Innovation Pharmaceuticals (USA - MA)
0000-00-00 brilacidin ulcerative proctitis/ulcerative proctosigmoiditis 2 Cellceutix (USA - MA), now Innovation Pharmaceuticals (USA - MA) Inflammatory diseases
0000-00-00 NV556 NASH (non-alcoholic steatohepatitis) preclinical Neurovive Pharmaceutical (Sweden) Liver diseases - Hepatic diseases
0000-00-00 psoriasis Merck&Co (USA - NJ) Sun Pharmaceutical Industries (India) Autoimmune diseases - Dermatological diseases - Inflammatory diseases